GoodRx (NASDAQ:GDRX) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating. They now have a $8.00 price target on the stock, down previously from $35.00. GoodRx (NASDAQ:GDRX) was downgraded by analysts at Raymond James from an "outperform" rating to a "market perform" rating.The current price is $7.72. GoodRx (NASDAQ:GDRX) was downgraded by analysts at SVB Leerink LLC from an "outperform" rating to a "market perform" rating. They now have a $10.00 price target on the stock, down previously from $33.00.